# Insulin Aspart

NDC: 73070-102
Generic name: insulin aspart
Labeler / Manufacturer: Novo Nordisk Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20010827

FDA application: BLA020986

## Active ingredients

- INSULIN ASPART: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73070-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73070-102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bee5b358-c863-420b-be73-ced2e920c499